• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Angiogenesis: In Vivo Systems, Part A

    Angiogenesis: In Vivo Systems, Part A by Cheresh, David A.;

    Series: Methods in Enzymology; 444;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 170.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        70 507 Ft (67 150 Ft + 5% VAT)
      • Discount 10% (cc. 7 051 Ft off)
      • Discounted price 63 457 Ft (60 435 Ft + 5% VAT)

    70 507 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Elsevier Science
    • Date of Publication 10 November 2008

    • ISBN 9780123743138
    • Binding Hardback
    • No. of pages400 pages
    • Size 228x152 mm
    • Weight 770 g
    • Language English
    • 0

    Categories

    Long description:

    "Angiogenesis is the growth of new blood vessels and is an important natural process in the body. A healthy body maintains a perfect balance of angiogenesis modulators. In many serious disease states, however, the body loses control over angiogenesis. Diseases that are angiogenesis-dependent result when blood vessels either grow excessively or insufficiently. Understanding how angiogenesis ""works"" and how to control it, will have massive implications on the management, treatments, and ultimately the prevention of many common (and not so common) diseases. Angiogenesis cuts across virtually every discipline. The Angiogenesis Foundation identified angiogenesis as a ""common denominator"" in our most serious diseases. Excessive angiogenesis occurs in diseases such as cancer, diabetic blindness, age-related macular degeneration, rheumatoid arthritis, psoriasis, and many other conditions. Insufficient angiogenesis occurs in diseases such as coronary artery disease, stroke, and delayed wound healing."

    More

    Table of Contents:

    Isolation of natural angiogenesis inhibitors and their function; Chick CAM models; Ultrastructure analysis of blood vessels; Zebrafish models; Lymphangiogenesis models and applications; Models of vascular permeability; Tumor models to study angiogenesis inhibitors; Studying hemangiomas and vascular malformations; Ocular models of angiogenesis; Models of ischemia and ischemia/reperfusion; Vascular neural patterns; Identification of important genes in vascular development; Imaging of tumor blood vessels; Imaging of blood vessels (in situ terminal models); In vivo assays to screen anti-angiogenic agents; Blood vessel normalization; Patterning (neurons, ECM, EC) during angiogenesis, vascular regression, inhibitors;

    More
    0